How Much Did Dedalus SpA Raise?
Funding & Key Investors

Dedalus SpA has solidified its position as a dominant force in the global healthcare software market, underscored by a total capital infusion of $67.7M. This trajectory of institutional backing reached a significant milestone with a recent strategic investment of $67.7M, marking a pivotal moment in the firm's expansion strategy. By securing this level of financing, the Florence-based industrial group reinforces its commitment to scaling its diagnostic and clinical management solutions across international borders, ensuring that its technological infrastructure remains at the forefront of the digital health revolution.

What is Dedalus SpA?

Dedalus SpA
SoftwareHealthcare Software

Founded in 1990, Dedalus SpA operates as a sophisticated international industrial group specializing in the complex ecosystem of healthcare information systems. The company provides a comprehensive suite of diagnostic and clinical management solutions, alongside specialized platforms for general practitioners, primary care management, and advanced interoperability. By facilitating seamless data exchange and population health management, Dedalus addresses the critical need for integrated digital workflows in modern medical environments. Its market position is defined by a deep-rooted expertise in clinical software, allowing it to serve as a backbone for healthcare providers seeking to optimize patient outcomes through data-driven insights and robust, scalable architecture.

How much funding has Dedalus SpA raised?

Dedalus SpA has raised a total of $67.7M across 1 funding round:

2014

Private Equity

$67.7M

Private Equity (2014): $67.7M with participation from Hutton Collins

Key Investors in Dedalus SpA

Hutton Collins

A private equity firm specializing in providing flexible capital solutions to established companies, often focusing on growth and strategic development.

What's next for Dedalus SpA?

With the infusion of $67.7M, Dedalus SpA is well-positioned to accelerate its strategic roadmap, focusing on the integration of next-generation interoperability standards and the expansion of its population health management capabilities. The company is expected to leverage this capital to deepen its footprint in key global markets, potentially through targeted acquisitions or the enhancement of its existing HCIS portfolio. As the healthcare sector continues to prioritize digital transformation, Dedalus is poised to capitalize on the increasing demand for unified clinical platforms. The firm's focus will likely remain on maintaining its competitive edge in the diagnostic software segment while scaling its primary care management solutions to meet the evolving requirements of international health systems.

See full Dedalus SpA company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Customer Engagement PlatformsSoftware
Healthcare SoftwareSoftwareEducationTraining
Financial SoftwareSoftware
Multimedia, Games & Graphics SoftwareSoftware

Frequently Asked Questions Regarding Dedalus SpA Financial Insights

What are the most recent funding rounds that Dedalus SpA has completed, and what were the funding rounds?
Dedalus SpA has recently completed 1 funding rounds: Private Equity on Jan 21, 2014.
What is the total amount of funding Dedalus SpA has raised to date?
Dedalus SpA has raised a total of $67.7M in funding to date.
How many funding rounds has Dedalus SpA completed?
Dedalus SpA has completed 1 funding rounds.
How much funding did Dedalus SpA raise in its most recent funding round?
Dedalus SpA raised $67.7M in its most recent funding round.
Who are the lead investors in Dedalus SpA's latest funding round?
The lead investor in Dedalus SpA's latest funding round was Hutton Collins. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Dedalus SpA's history?
The largest funding round in Dedalus SpA's history was $67.7M.
See more information about Dedalus SpA